Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pavitra Guddanti"'
Autor:
Nagapraveen Veerapu, Dhanashree P Inamdar, Baer P Ravi Kumar, Basavaraju Anuradha, Pavitra Guddanti, Sree D Issapuri, Nikhita S Ganta, Arun Gopi
Publikováno v:
Indian Journal of Community Medicine, Vol 47, Iss 4, Pp 587-590 (2022)
Background: In January 2021, India's drug regulator issued restricted emergency approval for COVISHIELD and COVAXIN, which were manufactured in India. In mid-January 2021, in India, there were 10.5 million confirmed cases and 0.15 million deaths. The
Externí odkaz:
https://doaj.org/article/95e908ac42f4459fa67855cef82615e5
Autor:
Nagapraveen Veerapu, Dhanashree P Inmdar, Baer P Ravi Kumar, Basavaraju Anuradha, Pavitra Guddanti, Sree D Issapuri, Nikhita S Ganta, Arun Gopi
BackgroundIn January 2021, India drug regulator issued restricted emergency approval for COVAXIN and COVISHIELD which were manufactured in India. On mid-January 2021, in India, there were 10.5million confirmed cases and 0.15 million deaths.Objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66ee5bfd63edf84c9ec843c1cd4d8b1e
https://doi.org/10.1101/2022.05.15.22273945
https://doi.org/10.1101/2022.05.15.22273945
